You searched for "regulation"
Intensive diabetes therapy and ocular surgery in type 1 diabetes
The Diabetes Control and Complications Trial (DCCT) ran between 1983 and 1993 and showed that intensive glycaemic control was beneficial in reducing diabetic retinopathy in type 1 patients. There was a 76% reduction in onset of retinopathy and a 52%...UK Eye Genetics Group Annual Conference
by Chloe M. Stanton, UK-EGG Treasurer, MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh Delegates including ophthalmic clinicians, clinical geneticists, genetic counsellors and research scientists travelled to Edinburgh from across the UK and Europe to attend...
Phaco-ECP vs. Phaco alone to treat glaucoma
This retrospective review compared combined phacoemulsification and endoscopic cyclophotocoagulation (phaco-ECP) to phaco alone in patients with mild to moderate glaucoma. Outcome measures included cumulative full and qualified success survival, postintervention IOP and ocular anti-hypertensive medication reduction. Full success was defined...
BT for Duane’s retraction syndrome esotropia
The aim of the study was to evaluate the correction of esotropia and face turn due to Duane’s retraction syndrome (DRS) type I. The mean age was 21 months (12-36 months). The mean dose of botulinum toxin (BT) was 5.6±1.8IU...Upper eyelid ulceration as a presenting sign of frontal sinus mucocele
Introduction A sinus mucocele is an epithelium-lined sac filled with mucus and desquamated epithelium. It forms secondary to inflammatory processes that occur in a sinus with an obstructed ostium. Predisposing conditions include previous trauma, surgery, tumours, anatomical abnormalities, and chronic...10 daily habits damaging your eyesight and changes you can make to remedy against them
Following World Glaucoma Day on 12 March this year, it is vital that the longevity of our vision is always a priority. However, many of our daily habits contribute to the onset of glaucoma and vision loss.
Outcomes of treat & extend ranibizumab in diabetic macular oedema
This study retrospectively evaluated 118 eyes of 87 patients who received ranibizumab in a treat and extend regimen for diabetic macular oedema (DMO). Data were collected for patients under follow-up for 24 months. After 24 months, patients gained a mean...
